Terms: = Ovarian cancer AND ATP2B3, PMCA3, 492, ENSG00000067842
65 results:
1. Current status and future perspectives in dysregulated miR-492.
Shen J; Si J; Wang Q; Mao Y; Gao W; Duan S
Gene; 2023 Aug; 877():147518. PubMed ID: 37295631
[TBL] [Abstract] [Full Text] [Related]
2. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
3. Spatial-Temporal Trends in ovarian cancer Outcomes in California.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36238987
[TBL] [Abstract] [Full Text] [Related]
4. CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients.
Manganaro L; Celli V; Viggiani V; Berardelli E; Granato T; Tartaglione S; Farina A; Catalano C; Angeloni A; Anastasi E
Tumour Biol; 2022; 44(1):171-185. PubMed ID: 36093649
[TBL] [Abstract] [Full Text] [Related]
5. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
6. Establishment and Verification of Logistic Regression Model for Qualitative Diagnosis of ovarian cancer Based on MRI and Ultrasound Signs.
Guo X; Zhao G
Comput Math Methods Med; 2022; 2022():7531371. PubMed ID: 35211186
[TBL] [Abstract] [Full Text] [Related]
7. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S; Harada M; Yoshioka N; Kajiyama H; Satoh T; Mikami M; Shozu M; Enomoto T; Osuga Y; Suzuki N
J Obstet Gynaecol Res; 2022 Mar; 48(3):806-816. PubMed ID: 34951514
[TBL] [Abstract] [Full Text] [Related]
8. A turn on fluorescent assay for real time determination of β-galactosidase and its application in living cell imaging.
Liu D; Zhang Z; Chen A; Zhang P
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 265():120345. PubMed ID: 34492512
[TBL] [Abstract] [Full Text] [Related]
9. Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers.
Perri T; Naor-Revel S; Eliassi-Revivo P; Lifshitz D; Friedman E; Korach J
Fertil Steril; 2021 Aug; 116(2):538-545. PubMed ID: 33823990
[TBL] [Abstract] [Full Text] [Related]
10. Markedly increased risk of malignancies in women with endometriosis.
Eoh KJ; Han M; Kim EH; Jung I; Kim YT
Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
[TBL] [Abstract] [Full Text] [Related]
11. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
[TBL] [Abstract] [Full Text] [Related]
12. Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.
Kim SR; Tone A; Kim RH; Cesari M; Clarke BA; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Lajkosz K; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh T; Pollett A; Ferguson SE
Gynecol Oncol; 2021 Apr; 161(1):221-227. PubMed ID: 33478752
[TBL] [Abstract] [Full Text] [Related]
13. A Collision between Cavernous-Capillary Hemangioma with Stromal Luteinization and Serous Cystadenoma.
Shopov ST
Folia Med (Plovdiv); 2020 Dec; 62(4):851-855. PubMed ID: 33415926
[TBL] [Abstract] [Full Text] [Related]
14. Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
Peretti U; Cavaliere A; Niger M; Tortora G; Di Marco MC; Rodriquenz MG; Centonze F; Rapposelli IG; Giordano G; De Vita F; Stuppia L; Avallone A; Ratti M; Paratore C; Forti LG; Orsi G; Valente MM; Gaule M; Macchini M; Carrera P; Calzavara S; Simbolo M; Melisi D; De Braud F; Salvatore L; De Lorenzo S; Chiarazzo C; Falconi M; Cascinu S; Milella M; Reni M
ESMO Open; 2021 Feb; 6(1):100032. PubMed ID: 33399070
[TBL] [Abstract] [Full Text] [Related]
15. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract] [Full Text] [Related]
16. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.
Wang Z; Liu Y; Wang M; Zhao J
J BUON; 2020; 25(2):797-804. PubMed ID: 32521870
[TBL] [Abstract] [Full Text] [Related]
17. Postoperative narcotic use in patients with ovarian cancer on an Enhanced Recovery After Surgery (ERAS) pathway.
Kay AH; Venn M; Urban R; Gray HJ; Goff B
Gynecol Oncol; 2020 Mar; 156(3):624-628. PubMed ID: 31882241
[TBL] [Abstract] [Full Text] [Related]
18. Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.
Yodsurang V; Tang Y; Takahashi Y; Tanikawa C; Kamatani Y; Takahashi A; Momozawa Y; Fuse N; Sugawara J; Shimizu A; Fukushima A; Hishida A; Furusyo N; Naito M; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Hirata M; Murakami Y; Kubo M; Matsuda K
PLoS One; 2018; 13(12):e0209096. PubMed ID: 30557369
[TBL] [Abstract] [Full Text] [Related]
19. Occupational Burden of Asbestos-Related Diseases in Korea, 1998-2013: Asbestosis, Mesothelioma, Lung cancer, Laryngeal cancer, and ovarian cancer.
Kang DM; Kim JE; Kim YK; Lee HH; Kim SY
J Korean Med Sci; 2018 Aug; 33(35):e226. PubMed ID: 30140191
[TBL] [Abstract] [Full Text] [Related]
20. Disparities in receipt of follow-up care instructions among female adult cancer survivors: Results from a national survey.
Wu J; Blair J; Izevbigie OC; Wright NC; Arend RC
Gynecol Oncol; 2018 Sep; 150(3):494-500. PubMed ID: 29970241
[TBL] [Abstract] [Full Text] [Related]
[Next]
